SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-288130
Filing Date
2014-07-31
Accepted
2014-07-31 06:12:11
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d754669d10q.htm 10-Q 479967
2 EX-31.1 d754669dex311.htm EX-31.1 7480
3 EX-31.2 d754669dex312.htm EX-31.2 7361
4 EX-32.1 d754669dex321.htm EX-32.1 4170
  Complete submission text file 0001193125-14-288130.txt   2974545

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT geva-20140630.xml EX-101.INS 356971
6 XBRL TAXONOMY EXTENSION SCHEMA geva-20140630.xsd EX-101.SCH 32196
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE geva-20140630_cal.xml EX-101.CAL 54330
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE geva-20140630_def.xml EX-101.DEF 68731
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE geva-20140630_lab.xml EX-101.LAB 246178
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE geva-20140630_pre.xml EX-101.PRE 163734
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23155 | Film No.: 141004435
SIC: 2836 Biological Products, (No Diagnostic Substances)